Veradigm PE Ratio 2010-2022 | MDRX

Current and historical p/e ratio for Veradigm (MDRX) from 2010 to 2022. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Veradigm PE ratio as of July 02, 2025 is 0.00.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

Veradigm PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2025-07-02 4.70 0.00
2022-12-31 17.64 $-0.25 0.00
2022-09-30 15.23 $0.43 35.42
2022-06-30 14.83 $0.43 34.49
2022-03-31 22.52 $1.12 20.11
2021-12-31 18.45 $1.01 18.27
2021-09-30 13.37 $5.15 2.60
2021-06-30 18.51 $5.03 3.68
2021-03-31 15.02 $4.83 3.11
2020-12-31 14.44 $4.64 3.11
2020-09-30 8.14 $-0.30 0.00
2020-06-30 6.77 $-0.33 0.00
2020-03-31 7.04 $-1.18 0.00
2019-12-31 9.82 $-1.09 0.00
2019-09-30 10.98 $1.17 9.38
2019-06-30 11.63 $1.00 11.63
2019-03-31 9.54 $2.26 4.22
2018-12-31 9.64 $2.08 4.63
2018-09-30 14.25 $-0.03 0.00
2018-06-30 12.00 $0.01 1200.00
2018-03-31 12.35 $-1.20 0.00
2017-12-31 14.55 $-1.09 0.00
2017-09-30 14.23 $-1.16 0.00
2017-06-30 12.76 $-1.06 0.00
2017-03-31 12.68 $-0.26 0.00
2016-12-31 10.21 $-0.14 0.00
2016-09-30 13.17 $-0.01 0.00
2016-06-30 12.70 $0.02 635.00
2016-03-31 13.21 $0.06 220.17
2015-12-31 15.38 $-0.01 0.00
2015-09-30 12.40 $-0.11 0.00
2015-06-30 13.68 $-0.23 0.00
2015-03-31 11.96 $-0.31 0.00
2014-12-31 12.77 $-0.37 0.00
2014-09-30 13.42 $-0.48 0.00
2014-06-30 16.05 $-0.60 0.00
2014-03-31 18.03 $-0.64 0.00
2013-12-31 15.46 $-0.59 0.00
2013-09-30 14.87 $-0.61 0.00
2013-06-30 12.94 $-0.29 0.00
2013-03-31 13.59 $-0.12 0.00
2012-12-31 9.42 $-0.02 0.00
2012-09-30 12.42 $0.26 47.77
2012-06-30 10.93 $0.32 34.16
2012-03-31 16.60 $0.36 46.11
2011-12-31 18.94 $0.39 48.56
2011-09-30 18.02 $0.22 81.91
2011-06-30 19.42 $0.12 161.83
2011-03-31 20.99 $0.14 149.93
2010-12-31 19.27 $0.08 240.88
2010-09-30 18.47 $0.23 80.30
2010-06-30 16.10 $0.22 73.18
2010-05-31 18.81 $0.12 156.75
2010-03-31 19.58 $0.12 163.17
2010-02-28 17.89 $0.09 198.78
2009-12-31 20.23 $0.09 224.78
2009-11-30 19.20 $0.09 213.33
2009-09-30 20.27 $0.09 225.22
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.509B $0.588B
Veradigm Inc. is a healthcare technology company which drives value through its combination of platforms, data, expertise, connectivity and scale. Its network features a dynamic community of solutions and partners providing advanced insights, technology and data-driven solutions. Veradigm Inc., formerly known as Allscripts Healthcare Solutions Inc., is based in CHICAGO.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $46.229B 58.81
Doximity (DOCS) United States $10.965B 50.76
Hims & Hers Health (HIMS) United States $10.735B 111.54
Tempus AI (TEM) United States $10.291B 0.00
IRhythm Technologies (IRTC) United States $4.659B 0.00
Inspire Medical Systems (INSP) United States $3.858B 60.28
Hinge Health (HNGE) United States $3.535B 0.00
Privia Health (PRVA) United States $2.748B 187.83
Enovis (ENOV) United States $1.886B 10.52
Phreesia (PHR) United States $1.695B 0.00
Schrodinger (SDGR) United States $1.512B 0.00
10x Genomics (TXG) United States $1.485B 0.00
Azenta (AZTA) United States $1.454B 67.57
Omnicell (OMCL) United States $1.402B 24.74
Clover Health Investments (CLOV) United States $1.400B 0.00
Evolent Health (EVH) United States $1.365B 116.30
Claritev (CTEV) United States $0.717B 0.00
Fulgent Genetics (FLGT) United States $0.606B 0.00
Standard BioTools (LAB) United States $0.490B 0.00
Butterfly Network (BFLY) United States $0.480B 0.00
Talkspace (TALK) United States $0.452B 135.00
Outset Medical (OM) United States $0.367B 0.00
TruBridge (TBRG) United States $0.353B 782.67
Health Catalyst (HCAT) United States $0.282B 0.00
Nyxoah SA (NYXH) Belgium $0.257B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.219B 0.00
KORU Medical Systems (KRMD) United States $0.170B 0.00
American Well (AMWL) United States $0.131B 0.00
EUDA Health Holdings (EUDA) Singapore $0.127B 0.00
Pulmonx (LUNG) United States $0.108B 0.00
MDxHealth SA (MDXH) Belgium $0.100B 0.00
CareCloud (CCLD) United States $0.096B 3.66
Insight Molecular Diagnostics (IMDX) United States $0.087B 0.00
111 (YI) China $0.061B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.050B 0.00
P3 Health Partners (PIII) United States $0.046B 0.00
HeartBeam (BEAT) United States $0.041B 0.00
Zepp Health (ZEPP) Netherlands $0.041B 0.00
Zhongchao (ZCMD) China $0.029B 0.00
Streamline Health Solutions (STRM) United States $0.023B 0.00
Precipio (PRPO) United States $0.017B 0.00
Bullfrog AI Holdings (BFRG) United States $0.015B 0.00
Healthcare Triangle (HCTI) United States $0.011B 0.00
Strata Skin Sciences (SSKN) United States $0.010B 0.00
MSP Recovery (MSPR) United States $0.010B 0.00
Predictive Oncology (POAI) United States $0.007B 0.00
Movano (MOVE) United States $0.005B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Evaxion - (EVAX) Denmark $0.003B 0.00
Tivic Health Systems (TIVC) United States $0.003B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.003B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00